According to Benitec Biopharma 's latest financial reports the company's current earnings (TTM) are -$21.7 M. a decrease over its 2022 earnings that were of -$18.85 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$21.81 M | 15.73% |
2022 | -$18.85 M | 6.01% |
2021 | -$17.78 M | 61.52% |
2020 | -$11.01 M | |
2017 | -$5.27 M | -20.7% |
2016 | -$6.65 M | -44.47% |
2015 | -$11.96 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -$2.17 M | -90.04% | Bahamas |
NRC Health
NRC | $40.37 M | -286.11% | ๐บ๐ธ USA |